Insulet Corporation balance sheet
At the end of fiscal 2025, Insulet Corporation had total assets of $3.19bn, total liabilities of $1.68bn and shareholders' equity of $1.52bn. It held $716m in cash against $949m of debt.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 128 | 113 | 94 | 57 | 150 | 151 | 123 | 137 | 273 | 114 | 214 | 907 | 806 | 690 | 704 | 953 | 716 | 535 |
| Receivables | — | 17 | 23 | 33 | 33 | 40 | 43 | 29 | 53 | 63 | 69 | 95 | 135 | 141 | — | — | 517 | 589 |
| Inventory | — | 11 | 12 | 15 | 9 | 13 | 12 | 36 | 33 | 71 | 101 | 154 | 303 | 347 | 403 | 430 | 453 | 485 |
| Total current assets | — | 142 | 133 | 110 | 198 | 208 | 191 | 370 | 547 | 461 | 591 | 1,249 | 1,330 | 1,314 | 1,583 | 1,891 | 1,914 | 1,849 |
| Goodwill | — | 0 | 38 | 38 | 38 | 37 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 52 | 52 | 52 | 52 | 52 |
| Total assets | — | 156 | 221 | 198 | 288 | 297 | 275 | 457 | 840 | 929 | 1,143 | 1,873 | 2,049 | 2,251 | 2,588 | 3,088 | 3,190 | 3,165 |
| Accounts payable | — | 5 | 11 | 9 | 19 | 15 | 15 | 13 | 24 | 26 | 55 | 54 | 38 | 31 | 19 | 20 | 75 | 123 |
| Deferred revenue (current) | — | 4 | 3 | 5 | 1 | 2 | 2 | 1 | 5 | 1 | 3 | 5 | 4 | 16 | 15 | 12 | 14 | 12 |
| Total current liabilities | — | 19 | 28 | 48 | 42 | 44 | 65 | 56 | 89 | 116 | 158 | 208 | 229 | 365 | 451 | 528 | 680 | 744 |
| Short-term debt | — | — | — | 14 | 0 | — | — | — | 0 | — | 0 | 16 | 25 | 28 | 49 | 84 | 18 | 19 |
| Long-term debt | — | 69 | 109 | 104 | 114 | 164 | 172 | 333 | 566 | 592 | 888 | 1,044 | 1,249 | 1,374 | 1,366 | 1,296 | 931 | 930 |
| Total debt | 0 | 69 | 109 | 118 | 114 | 164 | 172 | 333 | 566 | 592 | 888 | 1,059 | 1,274 | 1,402 | 1,416 | 1,380 | 949 | 948 |
| Total liabilities | — | 90 | 139 | 154 | 163 | 213 | 241 | 393 | 661 | 717 | 1,067 | 1,269 | 1,493 | 1,775 | 1,856 | 1,876 | 1,675 | 1,743 |
| Shareholders' equity | 62 | 66 | 83 | 44 | 125 | 84 | 34 | 63 | 179 | 212 | 76 | 604 | 556 | 476 | 733 | 1,212 | 1,515 | 1,422 |
| Shares outstanding | — | 45m | 48m | 48m | 55m | 56m | 57m | 57m | 58m | 59m | 63m | 66m | 69m | 70m | 70m | 70m | 70m | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | — | — | — | — | — | 517 | 545 | 589 |
| Inventory | 445 | 430 | 441 | 447 | 446 | 453 | 463 | 485 |
| Total current assets | 1,861 | 1,891 | 2,328 | 2,280 | 1,859 | 1,914 | 1,710 | 1,849 |
| Goodwill | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 52 |
| Total assets | 3,025 | 3,088 | 3,517 | 3,469 | 3,029 | 3,190 | 2,987 | 3,165 |
| Accounts payable | 40 | 20 | 58 | 96 | 48 | 75 | 150 | 123 |
| Deferred revenue (current) | 23 | 12 | 15 | 17 | 17 | 14 | 12 | 12 |
| Total current liabilities | 506 | 528 | 520 | 1,010 | 648 | 680 | 688 | 744 |
| Short-term debt | 42 | 84 | 83 | 461 | 80 | 18 | 19 | 19 |
| Long-term debt | 1,356 | 1,296 | 1,612 | 939 | 935 | 931 | 930 | 930 |
| Total debt | 1,398 | 1,380 | 1,695 | 1,400 | 1,015 | 949 | 948 | 948 |
| Total liabilities | 1,907 | 1,876 | 2,187 | 2,006 | 1,645 | 1,675 | 1,685 | 1,743 |
| Shareholders' equity | 1,118 | 1,212 | 1,331 | 1,463 | 1,384 | 1,515 | 1,303 | 1,422 |
| Shares outstanding | 70m | 70m | 70m | — | — | 70m | — | — |
Compare with peers
- Globus Medical Inc balance sheet
- Revvity balance sheet
- Quidelortho Corp balance sheet
- Enovis Corp balance sheet
- Teleflex Inc balance sheet
Head to head: GMED vs PODDPODD vs RVTYPODD vs QDEL
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies